✦ LIBER ✦

Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients

✍ Scribed by Holger Lode,Nikolai Siebert,Silke Kietz…

Book ID: 126381284
Publisher: Springer (Biomed Central Ltd.)
Year: 2013
Tongue: English
Weight: 79 KB
Volume: 1
Category: Article
ISSN: 2051-1426
DOI: 10.1186/2051-1426-1-S1-P244

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Validated detection of anti-GD2 antibody

Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab

✍ Siebert, Nikolai; Seidel, Diana; Eger, Christin; Brackrock, Diana; Reker, Daniel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 500 KB

Pharmacokinetics of human-mouse chimeric

Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients

✍ M. M. Uttenreuther-Fischer; C. S. Huang; A. L. Yu 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 834 KB

Phase I Trial of a Novel Anti-GD2 Monocl

Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma

✍ Navid, F.; Sondel, P. M.; Barfield, R.; Shulkin, B. L.; Kaufman, R. A.; Allay, J 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 247 KB